Quality of life in patients with progressive supranuclear palsy: one-year follow-up

Journal of Neurology

Volumn 262, Issue 9, 2015, Pages 2042-2048

  Pekmezović, Tatjana ^a   Ječmenica Lukić, Milica ^a   Petrović, Igor ^a   Špica, Vladana ^a   Tomić, Aleksandra ^a   Kostić, Vladimir S ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Follow up; Predictors; Progressive supranuclear palsy; Quality of life

Indexed keywords

ADULT; AGED; APATHY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; EFFECT SIZE; FEMALE; FOLLOW UP; HUMAN; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION; DISABILITY; HEALTH STATUS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE; THEORETICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APATHY; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROSPECTIVE STUDIES; QUALITY OF LIFE; SUPRANUCLEAR PALSY, PROGRESSIVE; SURVEYS AND QUESTIONNAIRES;

EID: 84941997766     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7815-3     Document Type: Article

References (36)

1. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1–9
2. Schrag A, Selai C, Quinn N, Lees A, Litvan I, Lang A, Poon Y, Bower J, Burn D, Hobart J (2006) Measuring quality of life in PSP. The PSP-QoL. Neurology 67(1):39–44
3. Brooks DJ (2002) Diagnosis and management of atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 72(Suppl. 1):10–16
4. Wenning GK, Litvan I, Tolosa E (2011) Milestones in atypical and secondary parkinsonisms. Mov Disord 26(6):1083–1095
5. Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, Quinn N (2004) Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 19(2):181–189
6. Higginson IJ, Gao W, Saleem TZ, Chaudhuri KR, Burman R, Mc Crone P, Leigh PN (2012) Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factors. PLoS One 7(11):e46327
7. Calvert M, Pall H, Hoppitt T, Eaton B, Savill E, Sackley C (2013) Health-related quality of life and supportive care in patients with rare long-term neurological conditions. Qual Life Res 22(6):1231–1238
8. Schrag A, Selai C, Davis J, Lees AJ, Jahanshahi M, Quinn N (2003) Health-related quality of life in patients with progressive supranuclear palsy. Mov Disord 18(12):1464–1469
9. Schrag A, Selai C, Quinn N, Hobart J (2005) Measuring health-related quality of life in patients with progressive supranuclear palsy. Neurocase 11(4):246–249
10. Schrag A, Sheikh S, Quinn NP, Lees AJ, Selai C, Mathias C, Litvan I, Lang AE, Bower JH, Burn DJ, Low P, Jahanshahi M (2010) A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Mov Disord 25(8):1077–1081
11. Winter Y, Spottke AE, Stamelou M, Cabanel N, Eggert K, Höglinger GU, Sixel-Doering F, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R (2011) Health-related quality of life in multiple system atrophy and progressive supranuclear palsy. Neurodegener Dis 8(6):438–446
12. Winter Y, Stamelou M, Cabanel N, Sixel-Döring F, Eggert K, Höglinger GU, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R, Spottke AE (2011) Cost-of-illness in multiple system atrophy and progressive supranuclear palsy. J Neurol 258(10):1827–1834
13. Jecmenica-Lukic M, Petrovic IN, Pekmezovic T, Kostic VS (2014) Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study. J Neurol 261(8):1575–1583
14. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442
15. Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130(Pt6):1552–1565
16. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6(4):278–286
17. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32(1):50–55
18. Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the Apathy Evaluation Scale. Psychiat Res 38(2):143–162
19. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44(12):2308–2314
20. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21(11):1078–1085
21. Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55(11):1621–1626
22. SF-36 Health Survey (Original version) Language Recalls. http://www.qualitymetric.com
23. Ware JE, Snow KK, Kosinski M (1993) The SF-36 health survey manual and interpretation guide. Nimrod Press, Boston
24. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Academic Press, New York
25. Gerstenecker A, Duff K, Mast B, Litvan I, ENGENE-PSP Study Group (2013) Behavioral abnormalities in progressive supranuclear palsy. Psychiatry Res 210(3):1205–1210
26. Benito-León J, Cubo E, Coronell C, ANIMO Study Group (2012) Impact of apathy on health-related quality of life in recently diagnosed Parkinson’s disease: the ANIMO study. Mov Disord 27(2):211–218
27. Aarsland D, Litvan I, Larsen JP (2001) Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 13(1):42–49
28. Borroni B, Alberici A, Agosti C, Cosseddu M, Padovani A (2009) Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy. Int Psychogeriatr 21(3):463–468
29. Varanese S, Perfetti B, Ghilardi MF, Di Rocco A (2011) Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson’s disease. PLoS One 6(3):e17846.3
30. Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, Currie J, Soo M, Olivieri G, Broe GA, Morris JG (2002) Frontal atrophy correlates with behavioral changes in progressive supranuclear palsy. Brain 125(Pt4):789–800
31. Agosta F, Galantucci S, Svetel M, Lukić MJ, Copetti M, Davidovic K, Tomić A, Spinelli EG, Kostić VS, Filippi M (2014) Clinical, cognitive, and behavioral correlates of white matter damage in progressive supranuclear palsy. J Neurol 261(5):913–924
32. Pedhazur EJ (1997) Multiple regression in behavioral research. Explanation and prediction. Wadsworth Publishing, Orlando
33. Meissner WG, Foubert-Samier A, Dupouy S, Gerdelat-Mas A, Debs R, Marquant F, De Cock VC, Rascol O, Tison F, Pavy-Le Traon A (2012) Assessment of quality of life with the multiple system atrophy health-related quality of life scale. Mov Disord 27(12):1574–1577
34. May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults CW, North American Multiple System Atrophy Study Group (2007) Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord 22(16):2371–2377
35. Köllensperger M, Stampfer-Kountchev M, Seppi K, Geser F, Frick C, Del Sorbo F, Albanese A, Gurevich T, Giladi N, Djaldetti R, Schrag A, Low PA, Mathias CJ, Poewe W, Wenning GK (2007) Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment. Eur J Neurol 14(1):66–72
36. Brown CA, Cheng EM, Hays RD, Vassar SD, Vickrey BG (2009) SF-36 includes less Parkinson disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures. Qual Life Res 18(9):1219–1237